cefdinir

Product NDC: 68788-8062
Requested package NDC: 68788-8062-1
11-digit product format: 687888062
Labeler code: 68788
Product ID: 68788-8062_7e9ca176-6bb8-49ea-a705-8a77cefd70d6
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: cefdinir
Dosage form: POWDER, FOR SUSPENSION
Route: ORAL
Labeler: Preferred Pharmaceuticals Inc.
Application: ANDA210534
Marketing category: ANDA
Marketing start: 2021-08-13
Marketing end: 0000-00-00
Substance: CEFDINIR
Active strength: 250 mg/5mL
Pharmacologic classes: Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	68788-8062	68788-8062-1	D	Discontinued by firm		2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A210534-001	CEFDINIR	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB		2021-02-19
A210534-002	CEFDINIR	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB		2021-02-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A210534-001	AB
A210534-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 68 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210534-001	CEFDINIR	125MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210534-002	CEFDINIR	250MG/5ML	FOR SUSPENSION / ORAL	AB	2021-02-19	`87673890dc5c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 68 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A210534-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A210534-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210534-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A210534-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A210534-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A210534-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210534-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A210534-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210534-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A210534-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210534-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A210534-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210534-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A210534-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210534-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A210534-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210534-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A210534-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A210534-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A210534-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210534-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A210534-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210534-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A210534-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210534-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A210534-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A210534-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A210534-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210534-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A210534-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A210534-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A210534-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A210534-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A210534-002	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A210534-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A210534-002	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A210534-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A210534-002	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210534-001	AB	1	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A210534-002	AB	1	`87673890dc5c…`

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68788-8062	CEFDINIR POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS INC.]	5	Legacy NDC	20250221_43131b6b-6cda-4bb6-b73b-9cfeb314d4e2.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
cefdinir	CEFDINIR	Preferred Pharmaceuticals Inc.	2e384d98-642e-4841-9f62-fcea4c242f4e	2026-03-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210534 application number: ANDA210534
cefdinir	CEFDINIR	A-S Medication Solutions	2bd2101c-511d-45a9-b1d8-a45ed40c5b80	2026-03-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210534 application number: ANDA210534
CEFDINIR	CEFDINIR	DIRECT RX	982d0f53-20bc-1cb4-e053-2995a90ad33c	2025-01-22	Warnings	Exact identifier application applno (ANDA): 210534 application number: ANDA210534
cefdinir	CEFDINIR	A-S Medication Solutions	7bbcc4ac-c964-4c6b-88c0-11c0ba9933db	2023-11-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210534 application number: ANDA210534
cefdinir	CEFDINIR	Ascend Laboratories, LLC	efb5a975-75ec-46e1-ba84-f68d0b9bf36f	2022-06-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 210534 application number: ANDA210534

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
CI0FAO63WC	CEFDINIR	91832-40-5	CEFDINIR

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
68788-8062-1	68788806201	100 mL in 1 BOTTLE (68788-8062-1)	100 ml	2021-08-13	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cefdinir for Oral Suspension USP Rx only	Preferred Pharmaceuticals Inc.	2025-02-18	HUMAN PRESCRIPTION DRUG LABEL	5